Nature Communications (Oct 2021)

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma

  • Bo Xu,
  • Lei Tian,
  • Jing Chen,
  • Jing Wang,
  • Rui Ma,
  • Wenjuan Dong,
  • Aimin Li,
  • Jianying Zhang,
  • E. Antonio Chiocca,
  • Balveen Kaur,
  • Mingye Feng,
  • Michael A. Caligiuri,
  • Jianhua Yu

DOI
https://doi.org/10.1038/s41467-021-26003-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 17

Abstract

Read online

Oncolytic herpes simplex virus-1 lyses cancer cells while increases their immunogenicity. Blocking the CD47 “don’t eat me” signal on cancer cells promotes their phagocytosis by macrophages. Authors here show that oncolytic viruses expressing anti-CD47 antibodies improve glioblastoma survival in mouse models.